Your browser doesn't support javascript.
loading
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis.
Laengle, Johannes; Kabiljo, Julijan; Hunter, Leah; Homola, Jakob; Prodinger, Sophie; Egger, Gerda; Bergmann, Michael.
Afiliação
  • Laengle J; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Kabiljo J; Ludwig Boltzmann Institute Applied Diagnostics, Medical University of Vienna, Vienna, Austria.
  • Hunter L; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Homola J; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Prodinger S; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Egger G; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Bergmann M; Ludwig Boltzmann Institute Applied Diagnostics, Medical University of Vienna, Vienna, Austria.
J Immunother Cancer ; 8(1)2020 01.
Article em En | MEDLINE | ID: mdl-31940587

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Ácido Valproico / Trastuzumab / Vorinostat Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Ácido Valproico / Trastuzumab / Vorinostat Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria País de publicação: Reino Unido